News

VACCELERATE Latest News

Open Calls for TRANSVAC2 Vaccine Development Services: Apply Now!

Vaccine Development Services: Deadline May 31st, 2022

Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization. To enable access to these skills and capacities, TRANSVAC2 offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use.

With the pandemic still ongoing, TRANSVAC2 is renewing its commitment to supporting academic and commercial vaccine developers through a new call for proposals dedicated to SARS-CoV-2 / COVID-19, with a special emphasis on variants of concern. Other project proposals will also be considered.

Services will be offered free of charge, with few exceptions. Academic and non-academic research groups, SMEs and industries can apply!

Are you a researcher?  Do you have good preliminary results, but need support to further develop your vaccine candidate? TRANSVAC2 R&D services might be a perfect match for you!

The transnational access (TNA) call runs until May 31st, 2022. For further information on services available and how to apply please visit www.transvac.org/transvac2.

EU-COVAT-2 BOOSTAVAC study start in Ireland

Ecraid begins its fight against infectious diseases. VACCELERATE is happy to support the project with an online Study Nurse Training Course & Certificate.

JUNE 14 2022 15:00 (CEST)

VACCELERATE Webinar with 2 Talks:
1. ENFORCE Study (Dr Joanne Reekie, Rigshospitalet Copenhagen, DK)
2. VATICO Study (Dr Eleftherios Mylonakis, Brown University, USA)

REGISTRATION: https://uni-koeln.zoom.us/webinar/register/WN_1wJ7m9s9RTKgWpsVl-k6HQ

Videos of the former VACCELERATE webinars can be found on YouTube: https://www.youtube.com/channel/UC1Gv0HDBdyG2Kk2UNo2HNDg

VACCELERATE Press Releases

15.03.2022 / VACCELERATE study on the effectiveness of a second booster shot begins in Ireland: https://twitter.com/vaccelerate_eu/status/1503688207506063360

22.02.2022 / Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier: Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier – Karolinska Universitetssjukhuset (cision.com)

05.11.2021 / Studie zur Wirksamkeit der „Boosterimpfung“ gegen Corona startet: https://portal.uni-koeln.de/universitaet/aktuell/presseinformationen/detail/studie-zur-wirksamkeit-der-boosterimpfung-gegen-corona-startet

22.07.2021 / Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants (European Commission): https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3803

12.04.2021 / Cologne’s university medicine to coordinate EU vaccine research network (Coimbra Group): https://newsletters.coimbra-group.eu/t/ViewEmail/j/4AD409F80C7A2CCF2540EF23F30FEDED/4013911B0F09E5BE4AB3169DA1FD82E9

16.03.2021 COMBACTE To Support Vaccine Trial Network VACCELERATE (Combacte): https://www.combacte.com/news/combacte-support-vaccine-trial-network-vaccelerate/

15.03.2021 / 12 Million for European COVID-19 Vaccine Research (Combacte): https://www.combacte.com/news/12-million-european-covid-vaccine-research/

18.02.2021 / Neues Konsortium koordiniert EU-Impfstoff-Forschungsnetzwerk: https://www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/neues-konsortium-koordiniert-eu-impfstoff-forschungsnetzwerk/

18.02.2021 / Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE (CECAD): https://www.cecad.uni-koeln.de/about/news/article/colognes-university-medicine-to-coordinate-eu-vaccine-research-network-vaccelerate/

17.02.2021 / EU to invest €150 million for research to counter coronavirus variants (European Commission): https://ec.europa.eu/info/news/eu-invest-eu150-million-research-counter-coronavirus-variants-2021-feb-17_en

 

VACCELERATE Press Review

27.03.2022 / Antibodies could determine fourth vaccine eligibility – study: https://www.rte.ie/news/coronavirus/2022/0327/1288742-coronavirus-antibodies/

24.01.2022 / VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment (THE LANCET Preprint): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4016606

06.01.2022 / Nach dem Booster: Brauchen wir bald noch eine vierte Impfung gegen Corona? (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-dem-booster-brauchen-wir-bald-noch-eine-vierte-impfung-gegen-corona–39359316

19.12.2021 / Die Vierte Impfung. Impfstoff gegen Omikron (Zeit): https://www.zeit.de/gesundheit/2021-12/omikron-variante-impfstoff

13.12.2021 / Mehrere Impfversuche bei initialen Non-Respondern machen“ (Ärzteblatt): https://www.aerzteblatt.de/nachrichten/129957/Mehrere-Impfversuche-bei-initialen-Non-Respondern-machen

08.12.2021 / Interview with Zoi D. Pana about the situation in Cyprus and the VACCELERATE network (Offsite): https://www.offsite.com.cy/eidiseis/topika/pana-gia-vaccelerate-den-kanei-toys-anthropoys-peiramatozoa

03.12.2021 / Interview with Oliver Cornely and Zoi D. Pana (Alpha Channel CY): https://twitter.com/vaccelerate_eu/status/1468558210437165059

23.11.2021 / Interview „Seit März 2020 im Lockdown“ (Kölner Stadt-Anzeiger): Print

15.11.2021 / Lietuvoje pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Lrytas): https://www.lrytas.lt/it/laboratorija/2021/11/15/news/lietuvoje-pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas-21407670

15.11.2021 / Pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Santaros Klinikos): https://www.santa.lt/naujienos/pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas/

12.11.2021 / Studie untersucht Booster-Effekt (Kölnische Rundschau): Print

12.11.2021 / Uni Köln Studie untersucht Booster-Effekt der Corona-Impfungen (Kölnische Rundschau): Uni Köln: Studie untersucht Booster-Effekt der Corona-Impfungen | Kölnische Rundschau (rundschau-online.de)

09.11.2021 / Studie zur Wirksamkeit der Booster-Impfung (Frankfurt Live): https://www.frankfurt-live.com/studie-zur-wirksamkeit-der-booster-impfung-136942.html

08.11.2021 /Neue Studie startet in Köln Wie gut sind Booster-Impfungen wirklich? (Kölner Stadt-Anzeiger): https://www.ksta.de/koeln/neue-studie-startet-in-koeln-wie-gut-sind-booster-impfungen-wirklich–39112684

03.11.2021 / Alle Infos zur Auffrischung Wann kann ich mir die Booster-Impfung gegen Corona holen? (Kölner Stadt-Anzeiger): Booster-Impfung: Wer braucht die dritte Impfdosis? | Kölner Stadt-Anzeiger (ksta.de)

26.10.2021 / Nach Kimmich-Aussage Was Experten zu Langzeitfolgen der Corona-Impfung sagen (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-kimmich-aussage-was-experten-zu-langzeitfolgen-der-corona-impfung-sagen-39087508

25.10.2021 / Uniklinik Köln sucht Probanden für Drittimpfung (WDR): TV

13.10.2021 / Studie zur Wirksamkeit der Booster-Impfung (Radio Köln): Radio

28.09.2021 / Zu langsam, zu mühsam, zu wenig (SZ): Print

27.09.2021 / Der geringe Beitrag der deutschen COVID-19-Forschung (Tagesspiegel): Print 

16.07.2021 / ECCMID 2021 TV: Talking trials with Oliver Cornely (ECCMID TV): https://www.youtube.com/watch?v=cKRC_2wYXEU

10.07.2021 / Hunderte Kölner trotz zweiter Impfung infiziert (Kölner Stadt-Anzeiger): Print

09.07.2021 / Zu wenig Antikörper? Was wir über die COVID-19-Todesfälle bei geimpften Kölnern wissen? (Kölner Stadt-Anzeiger)

30.06.2021 / Coronavirus: Government advisor part of €12m grant for Covid vaccine research (Cyprus Mail): https://cyprus-mail.com/2021/06/30/coronavirus-government-advisor-part-of-e12m-grant-for-covid-vaccine-research/

27.05.2021 / Aufholjagd: Das europäische Impfstoff-Netzwerk Vaccelerate (ARTE): https://www.arte.tv/de/videos/104080-000-A/aufholjagd-das-europaeische-impfstoff-netzwerk-vaccelerate/

12.05.2021 / Expert says at least one booster vaccine shot necessary (in-Cyprus): https://in-cyprus.philenews.com/expert-says-at-least-one-booster-vaccine-shot-necessary/

11.04.2021 / Pulse of Europe Rheinland: „Europa – Gesundheitspolitik für eine krisenfeste Zukunft?“ (Event): https://www.youtube.com/watch?v=NLR-ELvSyxo

 

 

VACCELERATE-related Scientific Publications

29.07.2021 / Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 (Lancet ID): https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00420-5/fulltext

27.05.2021 / Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS) (The Lancet, Preprint): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3854768

 

VACCELERATE Events

International Clinical Trials Day (ICTD) 2022

17 MAY 2022 Berlin, Germany

40th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) 

09-13 MAY 2022 Athens, Greece

World Vaccine Day 14 MAY 2022

On World Vaccine Day people around the world celebrate the benefits of vaccines. This day aims to raise awareness of the many positive contributions that vaccines make to our society. 

More information on https://worldvaccineday.org/.

23-26 APRIL 2022

32nd European Congress of Clinical Microbiology & Infectious Diseases, Lisbon, Portugal

1st Cypriot-Greek VACCELERATE Volunteer Registry Webinar with local National Patient Advocacy Groups 28 MARCH 2022

– To seek the support of PAG Members in completing the VAC PAG questionnaire (perspectives of PAGs for participation in clinical trials and volunteer registries)

– To invite them to join the VACCELERATE Volunteer Registry by becoming volunteers in our Cypriot Greek VAC platforms More than 12 PAGs participated

You can watch the video of the webinar (in Greek) here: https://www.youtube.com/watch?v=DNFNVe17mtg

The First World Conference Fighting COVID-19 Pandemic Health Challenges

26-28 MARCH 2022, Belgrade, Serbia.

VACCELERATE talk: Jon Salmanton-García: VACCELERATE: The pan-European backbone for the acceleration of phase 2 & 3 COVID-19 vaccine trials

1st VACCELERATE Annual Meeting 09-10 MARCH 2022

With a keynote lecture by top leading expert Stephen Lockhart  from Pfizer:
Vaccine Clinical Trials: Key Factors for Success – BNT162 as an Example.